Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]

Novakovic D, Feligioni M, Scaccianoce S, et al. Drug Des Devel Ther. 2013;7:1359–1364.On page 1362, left hand column, last sentence under Functional studies:The effects of gantenerumab on cognitive assessment in the Morris water maze test were inconclusive, as both wild-type and transgenic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Novakovic D (Author), Feligioni M (Author), Scaccianoce S (Author), Caruso A (Author), Piccinin S (Author), Schepisi C (Author), Errico F (Author), Mercuri NB (Author), Nicoletti F (Author), Nisticò R (Author)
Format:	Book
Published:	Dove Medical Press, 2014-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease
by: Novakovic D, et al.
Published: (2013)

Risk Factors for Alzheimer's Disease: Focus on Stress
by: Alessandra Caruso, et al.
Published: (2019)

Curcumin: a natural substance with potential efficacy in Alzheimer’s disease
by: Potter PE
Published: (2013)

Targeting neuroinflammation in Alzheimer’s disease
by: Bronzuoli MR, et al.
Published: (2016)

Targeting Synaptic Plasticity in Experimental Models of Alzheimer's Disease
by: Dalila Mango, et al.
Published: (2019)

Advances with RNA interference in Alzheimer’s disease research
by: Chen S, et al.
Published: (2013)

Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
by: Svob Strac D, et al.
Published: (2021)

Corrigendum: R-carvedilol, a potential new therapy for Alzheimer's disease
by: Jinjing Yao, et al.
Published: (2023)

Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease
by: Andreas Wentrup, et al.
Published: (2008)

Network Pharmacology and Molecular Docking Identify the Potential Mechanism and Therapeutic Role of Scutellaria baicalensis in Alzheimer’s Disease
by: Peng Y, et al.
Published: (2024)

Telepharmacy: a pharmacist’s perspective on the clinical benefits and challenges [Corrigendum]
by: Poudel A, et al.
Published: (2016)

The Relationship Between Alzheimer’s Disease and Skin Diseases: A Review
by: Zhang H, et al.
Published: (2021)

Non-Coding RNA in Microglia Activation and Neuroinflammation in Alzheimer’s Disease
by: He C, et al.
Published: (2023)

Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease
by: Fiona E McAlpine, et al.
Published: (2008)

Network Pharmacology and Molecular Docking Identify the Potential Mechanism and Therapeutic Role of Scutellaria baicalensis in Alzheimer’s Disease [Letter]
by: Yulion R, et al.
Published: (2024)

Screening strategies to identify HSP70 modulators to treat Alzheimer’s disease
by: Repalli J, et al.
Published: (2015)

Prevention and Treatment Strategies for Alzheimer’s Disease: Focusing on Microglia and Astrocytes in Neuroinflammation
by: Zhang S, et al.
Published: (2024)

LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
by: Atashrazm F, et al.
Published: (2016)

Periodontal Disease and Periodontal Disease-Related Bacteria Involved in the Pathogenesis of Alzheimer’s Disease
by: Matsushita K, et al.
Published: (2020)

Ginger components as new leads for the design and development of novel multi-targeted anti-Alzheimer’s drugs: a computational investigation
by: Azam F, et al.
Published: (2014)

Exploration of Influencing Factors for Postoperative Recurrence in Patients with Madelung’s Disease on the Basis of Multivariate Stepwise Cox Regression Analysis [Corrigendum]
by: Li S, et al.
Published: (2023)

Exploring the Therapeutic Potential of Phytochemicals in Alzheimer's Disease: Focus on Polyphenols and Monoterpenes
by: Ilaria Piccialli, et al.
Published: (2022)

Profile of atacicept and its potential in the treatment of systemic lupus erythematosus [Corrigendum]
by: Cogollo E, et al.
Published: (2015)

Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer’s disease in Japan
by: Montgomery W, et al.
Published: (2017)

Tetramethylpyrazine Improves Cognitive Function of Alzheimer’s Disease Mice by Regulating SSTR4 Ubiquitination
by: Weng G, et al.
Published: (2021)

Profile of infliximab in the treatment of pediatric Crohn’s disease
by: Kierus J, et al.
Published: (2015)

CORRIGENDUM Herbal Medicines in Brazil: Pharmacokinetic Profile and Potential Herb-Drug Interactions
by: Jose Maria Prieto, et al.
Published: (2015)

Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease
by: Rad SK, et al.
Published: (2018)

Identifying the Mechanisms and Molecular Targets of Yizhiqingxin Formula on Alzheimer’s Disease: Coupling Network Pharmacology with GEO Database
by: Zhang T, et al.
Published: (2020)

Impact of early intervention and disease modification in patients with predementia Alzheimer’s disease: a Markov model simulation
by: Budd D, et al.
Published: (2011)

A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer’s disease
by: Deardorff WJ, et al.
Published: (2016)

The epidemiology and burden of Alzheimer’s disease in Taiwan utilizing data from the National Health Insurance Research Database
by: Hung YN, et al.
Published: (2016)

MET Inhibitors for the Treatment of Gastric Cancer: What’s Their Potential?
by: El Darsa H, et al.
Published: (2020)

Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer's disease
by: Yunxia Luo, et al.
Published: (2023)

Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
by: Ravn A, et al.
Published: (2017)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
by: Ojha S, et al.
Published: (2015)

Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease
by: Marcus J. Calkins, et al.
Published: (2012)

Metformin’s Enigma: Bridging Gaps in Research on Potential Benefits & Associated Risks - A Critical Plea for Comprehensive Investigation [Letter]
by: Iqbal F, et al.
Published: (2024)

Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey [Corrigendum]
by: Ponzetti C, et al.
Published: (2017)

Ustekinumab in treatment of Crohn’s disease: design, development, and potential place in therapy
by: Deepak P, et al.
Published: (2016)